Trial intelligence / Profile preview

Effect of Appropriate Dose, Spectrum, and Timing of Antibiotics on 28-day Mortality in Patients with Sepsis in the Emergency Department

TCTR20211216003Completed

Sponsor
No
Start
Jul 2019
Countries
1
01

Overview

Open-label trial in sepsis, sponsored by No. Primary endpoint: 28-day all-cause mortality. Started Jul 2019; status: completed.

02

Conditions

sepsis

Beyond the preview

Go deeper on TCTR20211216003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20211216003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call